Feng Liu

发表

Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory

M. Day, K. Marquis, S. Grauer, 2008, Nature Neuroscience.

Cytoskeletal Changes Underlie Estrogen's Acute Effects on Synaptic Transmission and Plasticity

G. Lynch, Christopher Rex, F. Liu, 2009, The Journal of Neuroscience.

GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders

Feng Liu, Nicholas J. Brandon, Stephen J. Moss, 2009, Neuropharmacology.

Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders.

F. Liu, K. Marquis, M. Pangalos, 2009, Current molecular pharmacology.

Building a scientific framework for studying hormonal effects on behavior and on the development of the sexually dimorphic nervous system.

M. Day, Abby A. Li, L. Gray, 2008, Neurotoxicology.

Expression of NALP1 in cerebellar granule neurons stimulates apoptosis.

B. Ozenberger, F. Liu, Camelia Chiriac, 2004, Cellular signalling.

The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?

K. Marquis, S. Grauer, Radka Graf, 2009, Molecular and Cellular Neuroscience.

ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

F. Liu, M. Day, T. Comery, 2008, Journal of Pharmacology and Experimental Therapeutics.

Estrogen Receptor β Activity Modulates Synaptic Signaling and Structure

N. Brandon, D. Srivastava, P. Penzes, 2010, The Journal of Neuroscience.

WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent

F. Liu, M. Day, J. Dwyer, 2008, Neuropharmacology.

Rapid Estrogen Signaling in the Brain: Implications for the Fine-Tuning of Neuronal Circuitry

P. Mermelstein, F. Liu, T. Shors, 2011, The Journal of Neuroscience.

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

T. Comery, U. Egerland, M. Malamas, 2009, Journal of Pharmacology and Experimental Therapeutics.

The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Aβ peptides

K. Marquis, F. Liu, P. Reinhart, 2005 .

Phosphodiesterase 10 A Inhibitor Activity in Preclinical Models of the Positive , Cognitive , and Negative Symptoms of Schizophrenia

T. Comery, U. Egerland, M. Malamas, 2009 .

The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices.

F. Liu, K. Marquis, M. Bowlby, 2006, European journal of pharmacology.

Cytoskeletal Changes Underlie Estrogen's Acute Effects on Synaptic Transmission and Plasticity

G. Lynch, Christopher Rex, N. Brandon, 2009, The Journal of Neuroscience.

The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.

F. Liu, K. Marquis, P. Reinhart, 2005, Journal of neurochemistry.

The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?

K. Marquis, S. Grauer, Radka Graf, 2009, Molecular and Cellular Neuroscience.